TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 132 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $5,401,000 | -6.4% | 54,947 | +10.1% | 0.04% | -7.1% |
Q2 2018 | $5,771,000 | +16.3% | 49,890 | -0.7% | 0.04% | +16.7% |
Q1 2018 | $4,961,000 | -3.4% | 50,243 | +2.4% | 0.04% | 0.0% |
Q4 2017 | $5,138,000 | -15.1% | 49,061 | -9.1% | 0.04% | -7.7% |
Q3 2017 | $6,049,000 | 0.0% | 53,976 | 0.0% | 0.04% | -30.4% |
Q2 2017 | $6,049,000 | -2.0% | 53,976 | +2.0% | 0.06% | -3.4% |
Q1 2017 | $6,172,000 | +9.1% | 52,912 | -1.6% | 0.06% | +9.4% |
Q4 2016 | $5,659,000 | -8.8% | 53,754 | -4.3% | 0.05% | -8.6% |
Q3 2016 | $6,205,000 | +41266.7% | 56,149 | +56049.0% | 0.06% | – |
Q2 2016 | $15,000 | +7.1% | 100 | 0.0% | 0.00% | – |
Q1 2016 | $14,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |